Evaluation of anti-TNF therapeutic response in patients with inflammatory bowel disease: Current and novel biomarkers

Neutralizing tumour necrosis factor (TNF) antibodies have been widely used to treat inflammatory bowel disease (IBD) in the clinical practice. In this review, the principal biomarker analysis revealed that faecal calprotectin, C-reactive protein, serum or mucosal concentrations of anti-TNF monoclona...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Guanglin, Fan, Qingbo, Li, Zhenfeng, Goll, Rasmus, Florholmen, Jon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054158/
https://www.ncbi.nlm.nih.gov/pubmed/33862588
http://dx.doi.org/10.1016/j.ebiom.2021.103329

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054158/
https://www.ncbi.nlm.nih.gov/pubmed/33862588
http://dx.doi.org/10.1016/j.ebiom.2021.103329

Ejemplares similares